"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
| Descriptor ID |
D006680
|
| MeSH Number(s) |
D23.050.301.500.450 D23.050.705.552.450
|
| Concept/Terms |
HLA Antigens- HLA Antigens
- Antigens, HLA
- HL-A Antigens
- Antigens, HL-A
- HL A Antigens
- Human Leukocyte Antigens
- Antigens, Human Leukocyte
- Leukocyte Antigens, Human
- Leukocyte Antigens
- Antigens, Leukocyte
|
Below are MeSH descriptors whose meaning is more general than "HLA Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".
This graph shows the total number of publications written about "HLA Antigens" by people in this website by year, and whether "HLA Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 4 | 5 | 9 |
| 2011 | 3 | 1 | 4 |
| 2012 | 2 | 8 | 10 |
| 2013 | 6 | 5 | 11 |
| 2014 | 3 | 4 | 7 |
| 2015 | 6 | 4 | 10 |
| 2016 | 3 | 6 | 9 |
| 2017 | 8 | 2 | 10 |
| 2018 | 4 | 4 | 8 |
| 2019 | 3 | 3 | 6 |
| 2020 | 2 | 4 | 6 |
| 2021 | 3 | 3 | 6 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 5 | 5 |
| 2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA Antigens" by people in Profiles.
-
HLA loci heterozygosity modulates genetic risk in idiopathic inflammatory myopathies. Ann Rheum Dis. 2025 Oct; 84(10):1696-1705.
-
Risk factors for acute rejection in pediatric kidney transplantation. Transpl Immunol. 2025 Sep; 92:102273.
-
Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
-
Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions. Curr Diab Rep. 2025 Feb 08; 25(1):22.
-
Interplay between donor age and HLA-DP matching in 10/10?HLA-matched unrelated donor HCT. Blood Adv. 2024 10 22; 8(20):5438-5449.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
Distinct Non-Human Leukocyte Antigen Antibody Signatures Correlate with Endothelial Crossmatch Status in Lung and Renal Transplant Recipients. Int J Mol Sci. 2024 Sep 30; 25(19).
-
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 12; 30(12):1139-1154.
-
Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease. Endocr Pract. 2024 Nov; 30(11):1038-1043.
-
Insights into the genetic landscape of systemic sclerosis. Best Pract Res Clin Rheumatol. 2024 12; 38(4):101981.